期刊文献+

江西省药品生产企业人员对药品不良反应监测认知情况的调查分析 被引量:4

Investigation and Analysis of the Awareness of Pharmaceutical Enterprises Staff to ADR Monitoring in Jiangxi Province
原文传递
导出
摘要 目的:了解药品生产企业人员对药品不良反应(ADR)监测的认知程度,为提高药品生产企业ADR监测工作质量提供参考。方法:采用分层抽样法,选取江西省11个地级市的88家药品生产企业,利用经本课题组改良的德尔菲(Delphi)法设计药品生产企业人员对ADR监测的认知度测评量表,对上述企业882名从业人员进行问卷调查,并对结果进行统计和分析。结果:共发放问卷882份,回收有效问卷882份,有效回收率为100.0%。药品生产企业人员的ADR监测认知总分为20.49-90.57分,平均为(53.37±11.31)分。多元线性逐步回归分析结果显示,受教育程度、企业类型、企业开展过ADR监测培训、职称、企业员工数量、上报过ADR监测年度汇总表、接受过ADR监测培训等7个因素与受访者对ADR监测的认知程度存在线性关系。结论:江西省药品生产企业人员对ADR监测的认知程度总体较低。增强从业人员的受教育程度和专业能力、加强专业人员的培训、强化企业内部培训,可能有助于提高其认知程度。 OBJECTIVE: To understand the awareness of pharmaceutical enterprise staff to ADR monitoring, and to provide reference for the improvement of ADR monitoring in pharmaceutical enterprise. METHODS: Using stratified sampling method, 88 pharmaceutical enterprises were collected from 11 cities in Jiangxi province. Modified Delphi method was used to design awareness evaluation scale of ADR monitoring; questionnaire survey was carried out among 882 staffs, and then results were analyzed statistically. RESULTS: 882 questionnaires were sent out, and all questionnaires were available with effective recovery of 100.0%. The total awareness scores of pharmaceutical staff to ADR monitoring were 20.49-90.57, with average score of (53.37 ± 11.31). A linear stepwise regression analysis indicated that factors such as education, types of enterprise, conducting the training, occupational title, the number of employees, having reported the annual summary table and participating in the training were closely linked with awareness of interviewee to ADR monitoring. CONCLUSIONS : Pharmaceutical enterprises staff have weak awareness to ADR monitoring on the whole. It is helpful to improve the cognitive degree of staff by improving the level of education and professionally abilities, enhancing the training of professional staff and training within industry.
出处 《中国药房》 CAS CSCD 2014年第12期1073-1076,共4页 China Pharmacy
基金 江西省软科学研究计划项目(No.20122BBA10109)
关键词 江西省 药品生产企业 药品不良反应监测 认知度评估 回归分析 调查 Jiangxi provence Pharmaceutical enterprises ADR monitoring Awareness evaluation Regression analysis Investigation
  • 相关文献

参考文献10

二级参考文献31

共引文献43

同被引文献46

  • 1张继敏,平江.我国药品说明书存在的问题[J].中国药物经济学,2013,8(S1):400-401. 被引量:2
  • 2国家食品药品监督管理局.药品说明书和标签管理规定[EB/OL].2006-03-15[2009-01-12].http://www.sfda.gov.cn/WS01/CL0053/24522.html. 被引量:20
  • 3国家食品药品监督管理总局.药品不良反应报告和监测管理办法[EB/OL].[2011-05-04].http://www.sda.gov.cn/WS01/CL0053/62621_6.html. 被引量:8
  • 4国家食品药品监督管理局.关于印发化学药品和生物制品说明书规范细则的通知[EB/OL].[2014-01-16].http://v,ww.sfda.gov.cn/WS01/CL0055/10528.html. 被引量:2
  • 5百度百科.注射用头孢曲松钠[EB/OL].[2016-04-12].http://baike.baidu-com/link?url=TGU26IUeM9LKhl00B-DVlRCc0SfhczBqlbFSecWKg-t13h7wNIs2qGhr3cjs8·-kt7uStbAkd3RbChc4ss0AWV-a. 被引量:1
  • 6国家药品不良反应监测中心.警惕头孢曲松钠的严重过敏反应、头孢曲松钠临床使用中应注意的问题[EB/OL].(2008-12-16)[2016-04-12].http://www.cdr-adr.org.cn/xxtb一255/ypblfyxxtb/20081220081216-2814.html. 被引量:1
  • 7国家食品药品监督管理总局.注射用头孢曲松钠[EB/OL].[2016-04-12].http://appi.sfda.gov.cn/datasearch/face3/base.jsp. 被引量:1
  • 8齐鲁制药有限公司.注射用头孢曲松钠说明书[EB/OL].[2016-04-12].http://www.qilu-pharma.com/products-detail/&productld.59.html. 被引量:1
  • 9上海罗氏制药有限公司.注射用头孢曲松钠说明书[EB/OL].[2016-04-12].http://www.roche.tom.cn/content/dam/roche_china/zh_CN/pdf/product/rocephin-CMO.pd. 被引量:1
  • 10谢瑶,李光明.药品包装与说明书中的用药安全隐患分析[j].临床合理用药杂志,2013,6(6):83. 被引量:1

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部